Population pharmacokinetics and cerebrospinal fluid penetration of fluconazole in adults with cryptococcal meningitis

…, AS Castelazo, FM Kibengo… - Antimicrobial agents …, 2018 - Am Soc Microbiol
Robust population pharmacokinetic (PK) data for fluconazole are scarce. The variability of
fluconazole penetration into the central nervous system (CNS) is not known. A fluconazole PK …

[HTML][HTML] Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised …

…, L Lebina, J Makhura, N Mangxilana, FM Kibengo… - Ebiomedicine, 2023 - thelancet.com
Background The efficacy of on-demand HIV pre-exposure prophylaxis (PrEP) for men in sub-Saharan
Africa has not been evaluated, and the on-demand PrEP dosing requirement for …

[HTML][HTML] Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive …

…, Z Anywaine, AB Ggayi, FM Kibengo… - PLoS Neglected …, 2020 - journals.plos.org
Globally, early initiation of antiretroviral therapy for HIV led to a reduction in the estimated
mortality from cryptococcal meningitis (CCM) from 624,700 in 2009 to 181,100 in 2014. …

Population pharmacokinetic model and meta-analysis of outcomes of amphotericin B deoxycholate use in adults with cryptococcal meningitis

…, J Beardsley, S Whalley, FM Kibengo… - Antimicrobial agents …, 2018 - Am Soc Microbiol
There is a limited understanding of the population pharmacokinetics (PK) and pharmacodynamics
(PD) of amphotericin B deoxycholate (DAmB) for cryptococcal meningitis. A PK study …

[PDF][PDF] Trends of Reported HIV Sexual Risk Behaviour and HIV Incidence among Fisherfolk in Uganda Receiving Clinic-based Routine HIV Counseling and Testing

…, A Abaasa, E Ruzagira, FM Kibengo… - AIDS Research and …, 2014 - liebertpub.com
Background: HIV counseling and testing (HCT) has been shown to reduce HIV risk
behaviour and is central to HIV prevention programs. We investigated risk behaviour and HIV …

[PDF][PDF] Participation in Clinical Research Could Modify Background Risk for Trial Outcome Measures

…, U Bahemuka, E Ruzagira, FM Kibengo… - AIDS Research and …, 2014 - liebertpub.com
Background: Data on HIV incidence and retention are needed to inform study design of
efficacy trials. However, the selection criteria and interventions during an actual clinical trial …

The diagonostic value of Serum Cryptococcal Antigen Titres among HIV infected patients with suspected cryptococcal meningo-encephalitis attending Mulago …

MF Kibengo - 2004 - dspace.mak.ac.ug
Cryptococcal meningoencephalitis(CM) is the commonest, most important and most serious
opportunisitc infection of the central nervous system (CNS) among HIV-AIDS Patients.The …

[HTML][HTML] Factors Associated with Short and Long Term Mobility and HIV Risk of Women Living in Fishing Communities Around Lake Victoria in Kenya, Tanzania, and …

…, A Ssetaala, B Okech, B Oketch, FM Kibengo… - AIDS and Behavior, 2023 - Springer
Mobility is linked to negative HIV care continuum outcomes. We sought to understand factors
associated with short and long term mobility among women in fishing communities in Kenya…

[CITATION][C] Trends of Reported HIV Sexual Risk Behaviour and HIV Incidence Among Fisher Folk in Uganda Receiving Clinic-Based Routine HIV Counseling and …

…, UM Bahemuka, A Abaasa, E Ruzagira, FM Kibengo - 2009

[CITATION][C] Recruitment and Retention of a Highly Mobile Cohort of Fisherfolks At-risk of HIV Acquisition: Experience From a Rural Research Center in SW Uganda

FM Kibengo, U Bahemuka… - AIDS …, 2018 - MARY ANN LIEBERT, INC 140 …